9-(2-hydroxy-3-nonyl)adenine has been researched along with Cognition Disorders in 2 studies
9-(2-hydroxy-3-nonyl)adenine: specific inhibitor of adenosine deaminase
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bortolotto, JW | 1 |
| Melo, GM | 1 |
| Cognato, Gde P | 1 |
| Vianna, MR | 1 |
| Bonan, CD | 1 |
| Kimura, N | 1 |
| Okabayashi, S | 1 |
| Ono, F | 1 |
2 other studies available for 9-(2-hydroxy-3-nonyl)adenine and Cognition Disorders
| Article | Year |
|---|---|
Modulation of adenosine signaling prevents scopolamine-induced cognitive impairment in zebrafish.
Topics: Adenine; Adenosine; Adenosine Deaminase Inhibitors; Animals; Avoidance Learning; Cognition Disorders | 2015 |
Dynein dysfunction disrupts intracellular vesicle trafficking bidirectionally and perturbs synaptic vesicle docking via endocytic disturbances a potential mechanism underlying age-dependent impairment of cognitive function.
Topics: Adenine; Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Animals; Biological Transport; Brain | 2012 |